Life Sciences

IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery

Share this post:


Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer. Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool – tapping into Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology.

More Video Stories

How IHMI is Changing Health Care Delivery

Written by Watson Health | Blog Post, Cognitive Computing, Healthcare Data Analytics

A Q&A with James Madara, MD, CEO, American Medical Association on how health care delivery will be changing through an integrated-data approach model with IHMI. more

Jupiter Medical Center Adopts Watson for Oncology

Written by Watson Health | Oncology & Genomics, Video

Watch the video Jupiter Medical Center in south Florida is the first U.S. regional medical center to adopt Watson for Oncology. See how Watson is providing insights to help Jupiter’s clinicians deliver evidence-based cancer care in the community setting. more

Identifying the Right Patients and Saving Valuable Time

Written by Watson Health | Value-Based Care, Video

In this video, Rob Zimmerman, MD, Assistant Medical Director at Excela Health Medical Group shares how Excela uses IBM Watson Health tools to identify and contact patients with care gaps, and discusses the success the organization has achieved in bringing patients in for an office visit or preventative testing. more

Health Economist Jane Sarasohn-Kahn at HIMSS 17

Written by Watson Health | Healthcare Data Analytics, Video

Listen to Health Economist Jane Sarasohn-Kahn’s take on the future of artificial intelligence, consumer directed healthcare, and the importance of efficiently using clinical data at the 2017 HIMSS conference. more